Atossa Therapeutics
ATOS
#9429
Rank
S$0.10 B
Marketcap
S$0.83
Share price
-1.21%
Change (1 day)
-34.22%
Change (1 year)

Market capitalization of Atossa Therapeutics (ATOS)

Market cap: S$0.10 Billion

As of January 2026 Atossa Therapeutics has a market cap of S$0.10 Billion. This makes Atossa Therapeutics the world's 9429th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Atossa Therapeutics from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026S$0.10 B-1.9%
2025S$0.10 B-34.87%
2024S$0.16 B15.2%
2023S$0.14 B62.33%
2022S$89.71 M-67.25%
2021S$0.27 B358.33%
2020S$59.75 M209.2%
2019S$19.32 M137.23%
2018S$8.14 M-27.22%
2017S$11.19 M44.81%
2016S$7.73 M-47.71%
2015S$14.78 M-68.15%
2014S$46.41 M-14.99%
2013S$54.59 M-11.39%
2012S$61.61 M

End of Day market cap according to different sources

On Jan 11th, 2026 the market cap of Atossa Therapeutics was reported to be:

S$0.10 Billion
by Nasdaq info icon info icon
S$0.10 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$633.47 B 590,857.36%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
S$26.91 B 25,011.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
S$25.09 B 23,309.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
S$47.06 M-56.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
S$3.63 B 3,288.90%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
S$2.19 B 1,943.41%๐Ÿ‡บ๐Ÿ‡ธ USA